-
Pa Epulo 21, 2026, Center for Drug Evaluation (CDE) ya National Medical Products Administration idalengeza kuti HS-20093 yobayira jakisoni (risvutatug rezetecan) yasankhidwa kukhala njira yochizira odwala omwe ali ndi vuto la prostate losagonjetsedwa ndi kudulidwa kwa prostate ...Werengani zambiri»
-
Posachedwapa, Center for Drug Evaluation (CDE) ya China's National Medical Products Administration (NMPA) yalengeza kuti Encorafenib yavomerezedwa kwakanthawi kuti iwunikidwenso. Idzagwiritsidwa ntchito limodzi ndi cetuximab ndi FOLFOX chemotherapy regimen ngati chithandizo choyamba cha...Werengani zambiri»
-
Pamene mawu oti “khansa ya kapamba” akupezeka pa lipoti la matenda—makamaka pamene akuphatikizidwa ndi “ma metastases 25 a chiwindi”—mabanja ambiri akhala akutaya mtima. Matendawa, omwe amadziwika kuti “mfumu ya khansa,” omwe kale ankapezeka ndi ma metastases angapo, nthawi zambiri...Werengani zambiri»
-
Posachedwapa, Bayer adalengeza kuti bungwe la National Medical Products Administration (NMPA) la ku China lavomereza mankhwala atsopano otchedwa sevabertinib ochizira odwala akuluakulu omwe ali ndi khansa ya m'mapapo yomwe si yaing'ono (NSCLC) yomwe singathe kuchiritsidwa m'deralo kapena yomwe ili ndi kachilombo ka HER2 (ERBB2) komwe kamayambitsa matenda...Werengani zambiri»
-
Okondedwa Odwala Padziko Lonse, Pamene inu kapena okondedwa anu mukulimbana ndi khansa ndipo mukufuna njira zochiritsira zofewa komanso zothandiza, tikufuna kukudziwitsani za ukadaulo wosintha wa khansa — Ultrasound Tissue Fragmentation Therapy. Chithandizo chapamwambachi chagwiritsidwa ntchito bwino...Werengani zambiri»
-
Khansa ikasokoneza moyo, njira iliyonse yochizira imakhala ndi zotsatirapo zazikulu pa ubwino ndi ulemu wa moyo umenewo. Kwa odwala okalamba, omwe ali ndi vuto la mtima ndi mapapo, omwe sangathe kulekerera opaleshoni kapena mankhwala oletsa ululu, kapena kufunafuna njira yofewa yolimbana ndi chotupacho, ...Werengani zambiri»
-
Pa 31 Marichi, 2026, Center for Drug Evaluation of China's National Medical Products Administration idapereka nkhani yosangalatsa: GFH375, yopangidwa ndi GenFleet Therapeutics, yaphatikizidwa mwalamulo ngati "Breakthrough Therapy" yochizira odwala omwe ali ndi khansa ya kapamba yofalikira...Werengani zambiri»
-
Kwa odwala khansa okalamba ambiri ndi mabanja awo, matenda nthawi zambiri amabwera chifukwa cha kutaya mtima. Makamaka akakumana ndi "mfumu ya khansa" - khansa ya kapamba - ululu waukulu komanso kulephera kudya nthawi zambiri zimachotsa ulemu wawo kwa odwala, zomwe zimasiya okondedwa awo ali ndi chisoni chachikulu. Kuti...Werengani zambiri»
-
Pa Marichi 24, 2024, Center for Drug Evaluation of the China's National Medical Products Administration idalengeza kuti mankhwala atsopano a Teclistamab akuyembekezeka kusankhidwa ngati njira yochizira matenda a odwala akuluakulu omwe ali ndi matenda obwerezabwereza kapena osagwirizana ndi mankhwala ena ambiri omwe...Werengani zambiri»
-
Posachedwapa, bungwe la National Medical Products Administration (NMPA) lavomereza chizindikiro chatsopano cha antibody-drug conjugate (ADC) Disitamab vedotin pochiza odwala khansa ya m'mawere akuluakulu omwe ali ndi HER2-low expression yosasinthika kapena yofalikira (IHC 1+ kapena IHC 2+/ISH-) komanso metastases ya chiwindi, omwe ...Werengani zambiri»
-
Pa 10 Marichi, 2026, chipangizo chatsopano cha B7-H3-target antibody-drug conjugate (ADC) YL201 chobayira jakisoni, chopangidwa ndi MediLink Therapeutics, chinapatsidwa dzina la Breakthrough Therapy ndi Center for Drug Evaluation of China's National Medical Products Administration. Chizindikiro chomwe chatchulidwa...Werengani zambiri»
-
Posachedwapa, Center for Drug Evaluation (CDE) ya China National Medical Products Administration yavomereza mwalamulo jakisoni wa KSD-101, wopangidwa ndi Kousai, kuti ulowe m'mayesero azachipatala. Izi sizikutanthauza katemera woyamba woyamba wa dendritic cell (DC katemera) ku China kulandira pulogalamu ya FDA IND...Werengani zambiri»
Bungwe lachipatala logwirizana la Chipatala cha Khansa cha Beijing